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Reduced contribution of hypertension to the risk of
silent brain infarction in the elderly: a population-based
study in Takahata, Japan
INTRODUCTION
　Brain magnetic resonance imaging (MRI) 
frequently detects ischemic lesions in the 
healthy  elderly  people  with  no  stroke 
episodes 1), 2). The National Institute of Neuro-
logical  Disorders  and  Stroke  (NINDS)  has 
 proposed the term“asymptomatic cerebrovas-
cular disease” to describe patients who present 
with no neurological symptoms or dementia 
but have abnormal findings on brain CT or 
MRI examinations3). Subsequent studies have 
revealed that asymptomatic cerebrovascular 
disease is clinicaly important in that it is a 
high risk marker for future symptomatic 
stroke4), 5) and cognitive dysfunction6). Silent 
brain infarction (SBI), silent ischemic lesion 
and asymptomatic brain infarction are the 
synonyms for asymptomatic cerebrovascular 
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　The prevalence of asymptomatic ischemic brain lesions among the healthy elderly is 
high. We present a population-based cross sectional study of 240 subjects aged 70 years 
old (the Takahata Study), in which we have investigated the contributions of 
hypertension and other cerebrovascular risk factors to silent brain infarctions (SBI) in 
the elderly people. Of the 240 study subjects, 217 (90.4%) had SBIs. Hypertension was 
not significantly associated with SBIs. Further, diabetes melitus, hypercholesterolemia, 
habitual drinking or smoking were also not associated with SBIs. We concluded that 
aging may weaken the association of hypertension and other risk factors with 
asymptomatic ischemic brain lesions.
Key words : risk factor, asymptomatic cerebrovascular disease, elderly people, 
hypertension
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disease1). Here we have used SBI to describe 
the condition in which patients have no 
neurological and congnitive dysfunction but 
show brain ischemic lesions on MRI. Previous 
studies have suggested a number of risk factors 
for SBI, which are similar to those of 
symptomatic stroke5), 7). Accordingly, hyperten-
sion and aging are considered to be strong risk 
factors for both SBI and symptomatic stroke1). 
However,  while risk factors for symptomatic 
stroke have been studied extensively, those for 
SBI remain imcompletely understood1).
　Advances in the study of stroke have shown 
that some of the risk factors for symptomatic 
stroke diminish or lose their impact with 
advancing age. A recent meta-analysis of large 
epidemiological studies has suggested that the 
association of hypertension with symptomatic 
stroke appears to be weaker in the elderly7).  
Based on this finding, it is assumed that 
hypertension may have either a weak or no 
relationship with SBI in the elderly; however, 
no investigation has been performed to 
evaluate this assumption. The current study, a 
population-based cross sectional study, aimed 
to examine whether hypertension is associated 
with SBI in the elderly people.
SUBJECTS AND METHODS
Subjects
  The subjects of the study included 269 
healthy individuals who were 70 years old at 
the time of examination. The subjects were 
recruited from a healthcare examination 
conducted in the town of Takahata, Yamagata, 
a rural area in the northern part of Japan 
(Fig.1). The oficial population statistics 
showed that there were 350 individuals aged 
70 years in the town,: 269 (76.9%) of them 
participated in this study. The remaining 81 
individuals did not participate, because they 
were under medication in hospitals, were 
wheel-chair dependent, or had other reasons 
for non-participation. Al the subjects who 
participated in the study provided written 
informed consent, and the Medical Committee 
of Yamagata University School of Medicine 
approved the study.
METHODS
　The characterisitics of the subjects were 
assessed using standardized questionnaires， 
physical and neurological examinations, elec-
trocardiography and laboratory examinations. 
The questionnaire included items related to 
the medical history, present medications, and 
smoking and drinking habits. Physical and 
neurological examinations were performed by 
qualified neurologists, and cognitive function 
was evaluated using a mini-mental state 
examination and revised edition of Hasegawa 
dementia scale. Subjects with a medical history 
of symptomatic stroke or transient ischemic 
attack, and those with neurological abnormali-
ties, were excluded from the study, because of 
the possibility of symptomatic stroke. Labora-
tory examinations included complete blood cel 
counts, liver and renal function tests, and 
measurement of hemoglobin A1c (HbA1c), uric 
acid, total cholesterol, and HDL cholesterol 
levels.
DEFINITION OF RISK FACTORS
　The risk factors were defined as described in 
the Funagata Study8): a population-based 
study with a study design identical to the 
present  study  design.  Hypertension  was 
defined to be present if the subject had a 
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systolic blood pressure of ≧160 mmHg or a 
diastolic blood pressure of ≧ 95 mmHg. Sub-
jects with a medical history of hypertension or 
those receiving prescribed antihypertensive 
medications were also defined as having 
hypertension. Diabetes melitus was defined to 
be present if the value of HbA1c was ≧6.5% 
(normal range ≦6.4%). Subjects with a 
medical history of diabetes or those receiving 
prescribed anti-diabetic drugs or being treated 
with insulin injections were also considered to 
have diabetes. Subjects with a serum choles-
terol concentration ≧220 mg/dl were said to 
have hypercholesterolemia. The presence of 
hyperurticemia was defined as a serum uric 
acid concentration of ≧8.0 mg/dl. Those with a 
medical history of hypercholesterolemia and 
hyperurticemia or those under medications for 
the hypercholesterolemia and hyperurticemia 
were said to have hypercholesterolemia and 
hyperuricemia, respectively. The presence of 
atrial fibrilation or ischemic heart disease was 
determined by routine 12-lead electrocar-
diography.
　Fig. 1. Location of Takahata, Japan
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BRAIN MRI STUDY
　Brain MRI study was performed using a 0.3 
T system (Elias; Hitachi-Medico, Japan). 
Transverse images were obtained as 7-mm 
thick sections. T1-weighted images (TR 500ms, 
TE 20 ms), T2-weighted images (TR 3500 ms, 
TE 112 ms) and fluid-attenuated inversion 
recovery (FLAIR) images (TR 6700 ms, TE 117 
ms) were obtained. Al the brain MRI images 
were evaluated by a qualified neuroradiologists 
who did not have any prior clinical information 
about the subjects. A high-intensity lesion on 
both T2-weighted and FLAIR images was 
considered to indicate an ischemic lesion. A 
high intensity lesion on T2-weighted images 
and a low intensity on T1-weighted images was 
considered to be an old cystic infarct, and was 
thus included as an SBI9). A smal round spot 
(3 mm in diameter) that had a signal intensity 
identical to that of cerebrospinal fluid on T2-
weighted and FLAIR images was considered to 
be an enlarged perivascular space10), and thus 
excluded from the SBI lesions.  Ischemic 
lesions were scored according to their number 
and size (Table 1).
STATISTICAL ANALYSIS
　Using ischemic rating score (Table 1), 
incidence of ischemic brain lesions was 
expressed as the mean ± standard error (SE). 
Subjects were divided into 2 groups; those with 
hypertension and without hypertension. Mann-
Whitney U-test was used to analyze the 
statistical diference between the 2 groups. 
Further, subjects were divided into 2 groups 
(Table 3): those with SBIs and those without 
SBIs. The data are expressed as the mean ± 
standard error (SE) and Mann-Whitney U-test 
was used to analyze the statistical significance 
of the diferences in the variants between the 2 
groups. Each candidate risk factors for SBI was 
evaluated by a multiple regression analysis or a 
multiple logistic regression analysis. In the 
multiple logistic regression analysis, a total 
ischemic score of ≧1 was defined as the 
presence of an ischemic brain lesion and a 
score of zero reflected the absence of a lesion. 
Statistical analyses were carried out using 
SPSS software. Statistical significance was set 
at a two tailed p value ＜0.05.
　Table 1. Scores of the Ischemia Rating Scale
Basal ganglia, thalamus,
brainstem, and cerebelumCerebral white matter Score 
No lesionNo lesion0
One or more lesion of <5 mm in size
One or more lesion of <5 mm in size
and/or
1-5 lesions of 5-9 mm in size
1
 
 One or more lesion of 5-9 mm in size
≧6 lesions of 5-9 mm in size
and/or
One or more lesion of ≧10 mm in size
2 
One or more lesion of ≧10 mm in sizeDiffuse lesion3
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RESULTS
　Of the initial 269 subjects, 24 were excluded 
from the study because of a medical history of 
transient ischemic attack (TIA) or sympto-
matic stroke (14 individuals), and the presence 
of cognitive dysfunction (10 individuals). Five 
individuals were excluded because they had 
not been examined by neurologists. Finaly, a 
total of 240 subjects (86 men and 154 women) 
were included in the study (Fig.2).
　The incidence of the brain ischemic lesions 
was estimated with the ischemia rating scale 
and the total score on the scale was correlated 
with the presence of hypertension (Table 2). 
The scores of the various brain regions showed 
no significant diference except for the 
thalamus, which had an increased score in the 
subjects with hypertension.
　The characteristics of the 240 subjects are 
summarized in Table 3. Of the study subjects, 
217 (90.4%) had one or more ischemic lesions, 
and 23 subjects (9.6%) had no ischemic lesions. 
There were no statisticaly significant difer-
ences between the characteristics of the 2 
groups. Laboratory examinations showed that 
serum concentrations of cholesterol, uric acid 
　Table 2. Incidence of brain ischemic lesions
without hypertension
n=89
with hypertension
n=151
78(88%)139(92%)Brain lesion
Score
0.7±0.10.8±0.04　　Subcortical white matter
1.2±0.11.3±0.1　　Deep white matter
0.7±0.11.0±0.1　　Basal ganglia
0.1±0.03*0.3±0.04*　　Thalamus
0.1±0.040.2±0.04　　Brainstem
0.1±0.040.1±0.03　　Cerebelum
2.8±0.2*3.6±0.2*Total scores
Data are mean±SE. *p<0.05 by Mann-Whitney U-test.
　Table 3. Characteristics of subjects with and without asymptomatic ischemic lesions
Without Ischemic Lesion
n=23
With Ischemic Lesion
n=217
n.s. 9/1477/140Sex(Men/Women)
n.s.12 (52.2%)139 (64.1%)Hypertension 
n.s. 2 (8.7%) 31 (14.3%)Diabetes Melitus
n.s. 7 (30.4%) 80 (36.9%)Hypercholesterolemia
n.s. 0 (0.0%)  21 (9.7%)Hyperuricemia 
n.s. 0 (0.0%)  5 (2.3%)Atrial fibrilation
n.s. 2 (8.7%) 14 (6.5%)Excessive drinking
n.s. 9 (39.1%) 70 (32.3%)Smoking
n.s. : not significant
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and creatinine did not difer significantly 
between the 2 groups.  The frequency of 
associated conditions, such as diabetes, was 
similar between the 2 groups.  Data from the 
questionnaire showed that there had hardly 
been any movement of the population in 
Takahata town, particularly among the elderly 
aged around 70 years.  Hence, most of the 
subjects had spent their life in the same 
natural environment and had folowed the 
ethnic lifestyle of the area.
　Table 4 shows the results of multiple logistic 
regression analysis for the candidate risk 
factors of SBI. The odds ratio for hypertension 
was 1.39 (95% confidence interval: 0.57-3.40, 
p=0.48), indicating that hypertension was not 
significantly associated with SBI. None of the 
other factors was found not to be a significant 
independent risk factors for SBI.
DISCUSSION
　Hypertension has been considered to be a 
strong risk factor for SBI and symptomatic 
Fig. 2. Flow chart of the study population
　Table 4. Risk factors for ischemic lesion by multiple logistic regression analysis
p95%CIOdds ratio
0.560.14－2.930.64Sex (Female/Male)
0.480.57－3.401.39Hypertension
0.380.43－9.281.99Diabetes Melitus
0.610.48－3.461.29Hypercholesterolemia
0.690.13－3.920.70Excessive drinking
0.700.16－3.370.74Smoking
CI : confidence interval.
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stroke1). In accordance with the previous 
study1), the total score and the score for the 
thalamus on the ischemic rating scale was 
significantly increased in the hypertensive 
subjects (Table 2). However, the comparison 
between the subjects with SBI and those 
without SBI showed that hypertension is not 
significantly associated with SBI (Table 3). A 
possible explanation for the discrepancy is that 
the diferent estimation methods of the brain 
ischemic lesions could result in the diferences 
in the power of the statistical tests. Using the 
ischemia rating score (Table 1), the significant 
association between hypertension and SBI was 
demonstrated, possibly because not only the 
presence or absence of SBI but also severity of 
number and size of the ischemic lesions were 
included in the scoring. On the other hand, the 
comparison between subjects with SBI and 
those without SBI, the power of the statistical 
tests could be weak, resulting in failure to 
detect the significant association between SBI 
and hypertension (Table 3).
　Another implication of the present study can 
be noted by a comparison of the present study 
with the Funagata study8), which was also 
performed as a population-based cross sec-
tional study that investigated the association 
between hypertension or other risk factors and 
SBI.  Although  their  study  design  was 
essentialy the same as that used in our study, 
the study subjects in the Funagata study were 
younger (mean age of the subjects in the 
Funagata study, 60 years). The odds ratio (OR) 
of hypertension for SBI was 3.06 (95% CI, 1.33-
7.14) and 1.39 (95% CI, 0.57-3.40) in the 
Funagata  study  and  the  present study, 
respectively.  Because the other risk factors did 
not difer between the two studies, we 
speculate that the contribution of hypertension 
to SBI may be lower among the eldery. In the 
Second Manifestations of ARTrial disease 
study11), 308 subjects with a mean age of 58 
years old were examined, and the OR for 
hypertension was found to be 2.2 (95% CI, 1.2-
4.2). On the other hand, in the Rotterdam Scan 
Study2), 513 subjects with a mean age of 71 
years old were examined, and the OR for 
hypertension was 1.2 (95% CI, 0.6-2.4).
　A similar age-related phenomenon has been 
observed in cerebrovasucular diseases includ-
ing ischemic stroke.  Based on the Hisayama 
study12), Arima et al. found no association 
between hypertension and cardiovascular 
disease in elderly Japanese subjects aged 80 
years and older. A further example is provided 
by the Framingham study13), which showed a 
gradual decrease in the relative risk (RR) of 
hypertension for stroke with advancing age; 
the estimated RR was 3.5 in subjects aged 50-
59 years old, but only 1.7 in subjects aged 80-89 
years.
　The present study has several limitations. 
The primary limitation is that the definition of 
hypertension was dependent on blood pressure 
measurements recorded on a single day. 
Although such measurements are reported to 
be acceptable in epidemiological studies14), 
hypertension could have been underdiagnosed 
in the present study.  However, in comparison 
with the Funagata study8), which used a study 
design identical to that of the present study, we 
demonstrated weakening of the association 
between hypertension and SBI with advancing 
age. A second limitation is the number of the 
subjects without hypertension (n=23) was 
smal, as compared with that of hypertensive 
subjects (n=217) (Table 3). This may reduce 
the statistical power, which may fail to detect 
the diference between the two groups. A third 
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limitation of our study is that some risk factors 
were not entirely evaluated. Hence, the 
contribution of atrial fibrilation and hyperuri-
cemia to SBIs could not be estimated because 
of the smal number of cases.
　In conclusion, we have found that hyperten-
sive risks for the elderly appear to be diferent 
from those for the middle-aged population. 
Therefore, to establish the evidence-based 
medicine for the elderly, clinical evidence 
should be obtained from the elderly, but not 
from the middle-aged people.
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